C08B 37/0021

Dextran, i.e. -d-glucan

Official title: {Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran}

C08B37/0021 (Dextran, i.e. -d-glucan) appears on 354 US grants and 398 published applications in this corpus.

Search patents in C08B
Granted patents
354
Published applications
398
Assignees
283
Inventors
885
Latest grant
15 Sep 2026

Filings by year

C08B 37/0021: granted patents and published applications per publication year
YearGranted patentsPublished applications
197620
197750
197850
197900
198020
198120
198210
198340
198400
198510
198640
198730
198870
198940
199070
199130
199250
199320
199420
199540
199640
199740
1998110
199990
200010
200133
2002813
20031216
20041115
2005812
2006129
200733
2008414
2009212
2010517
2011414
2012720
20131529
20141417
20151317
20161517
20171320
20181322
20191616
20202217
20211315
20221117
2023821
20241417
2025915
2026710

By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.

Recent patents

Most cited

By later US patents